Global TCR-T Therapy Market Insights and Forecast to 2028

Table Of Contents

1 Report Business Overview

1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global TCR-T Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Autologous 1.2.3 Allogeneic 1.3 Market by Application 1.3.1 Global TCR-T Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Refractory Relapsed Melanoma 1.3.3 Synovial Sarcoma 1.3.4 Multiple Myeloma 1.3.5 Lung Cancer 1.3.6 Other 1.4 Study Objectives 1.5 Years Considered2 Global Growth Trends 2.1 Global TCR-T Therapy Market Perspective (2017-2028) 2.2 TCR-T Therapy Growth Trends by Region 2.2.1 TCR-T Therapy Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 TCR-T Therapy Historic Market Size by Region (2017-2022) 2.2.3 TCR-T Therapy Forecasted Market Size by Region (2023-2028) 2.3 TCR-T Therapy Market Dynamics 2.3.1 TCR-T Therapy Industry Trends 2.3.2 TCR-T Therapy Market Drivers 2.3.3 TCR-T Therapy Market Challenges 2.3.4 TCR-T Therapy Market Restraints3 Competition Landscape by Key Players 3.1 Global Top TCR-T Therapy Players by Revenue 3.1.1 Global Top TCR-T Therapy Players by Revenue (2017-2022) 3.1.2 Global TCR-T Therapy Revenue Market Share by Players (2017-2022) 3.2 Global TCR-T Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by TCR-T Therapy Revenue 3.4 Global TCR-T Therapy Market Concentration Ratio 3.4.1 Global TCR-T Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by TCR-T Therapy Revenue in 2021 3.5 TCR-T Therapy Key Players Head office and Area Served 3.6 Key Players TCR-T Therapy Product Solution and Service 3.7 Date of Enter into TCR-T Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans4 TCR-T Therapy Breakdown Data by Type 4.1 Global TCR-T Therapy Historic Market Size by Type (2017-2022) 4.2 Global TCR-T Therapy Forecasted Market Size by Type (2023-2028)5 TCR-T Therapy Breakdown Data by Application 5.1 Global TCR-T Therapy Historic Market Size by Application (2017-2022) 5.2 Global TCR-T Therapy Forecasted Market Size by Application (2023-2028)6 North America 6.1 North America TCR-T Therapy Market Size (2017-2028) 6.2 North America TCR-T Therapy Market Size by Type 6.2.1 North America TCR-T Therapy Market Size by Type (2017-2022) 6.2.2 North America TCR-T Therapy Market Size by Type (2023-2028) 6.2.3 North America TCR-T Therapy Market Share by Type (2017-2028) 6.3 North America TCR-T Therapy Market Size by Application 6.3.1 North America TCR-T Therapy Market Size by Application (2017-2022) 6.3.2 North America TCR-T Therapy Market Size by Application (2023-2028) 6.3.3 North America TCR-T Therapy Market Share by Application (2017-2028) 6.4 North America TCR-T Therapy Market Size by Country 6.4.1 North America TCR-T Therapy Market Size by Country (2017-2022) 6.4.2 North America TCR-T Therapy Market Size by Country (2023-2028) 6.4.3 United States 6.4.4 Canada7 Europe 7.1 Europe TCR-T Therapy Market Size (2017-2028) 7.2 Europe TCR-T Therapy Market Size by Type 7.2.1 Europe TCR-T Therapy Market Size by Type (2017-2022) 7.2.2 Europe TCR-T Therapy Market Size by Type (2023-2028) 7.2.3 Europe TCR-T Therapy Market Share by Type (2017-2028) 7.3 Europe TCR-T Therapy Market Size by Application 7.3.1 Europe TCR-T Therapy Market Size by Application (2017-2022) 7.3.2 Europe TCR-T Therapy Market Size by Application (2023-2028) 7.3.3 Europe TCR-T Therapy Market Share by Application (2017-2028) 7.4 Europe TCR-T Therapy Market Size by Country 7.4.1 Europe TCR-T Therapy Market Size by Country (2017-2022) 7.4.2 Europe TCR-T Therapy Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries8 Asia-Pacific 8.1 Asia-Pacific TCR-T Therapy Market Size (2017-2028) 8.2 Asia-Pacific TCR-T Therapy Market Size by Type 8.2.1 Asia-Pacific TCR-T Therapy Market Size by Type (2017-2022) 8.2.2 Asia-Pacific TCR-T Therapy Market Size by Type (2023-2028) 8.2.3 Asia-Pacific TCR-T Therapy Market Share by Type (2017-2028) 8.3 Asia-Pacific TCR-T Therapy Market Size by Application 8.3.1 Asia-Pacific TCR-T Therapy Market Size by Application (2017-2022) 8.3.2 Asia-Pacific TCR-T Therapy Market Size by Application (2023-2028) 8.3.3 Asia-Pacific TCR-T Therapy Market Share by Application (2017-2028) 8.4 Asia-Pacific TCR-T Therapy Market Size by Region 8.4.1 Asia-Pacific TCR-T Therapy Market Size by Region (2017-2022) 8.4.2 Asia-Pacific TCR-T Therapy Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America TCR-T Therapy Market Size (2017-2028) 9.2 Latin America TCR-T Therapy Market Size by Type 9.2.1 Latin America TCR-T Therapy Market Size by Type (2017-2022) 9.2.2 Latin America TCR-T Therapy Market Size by Type (2023-2028) 9.2.3 Latin America TCR-T Therapy Market Share by Type (2017-2028) 9.3 Latin America TCR-T Therapy Market Size by Application 9.3.1 Latin America TCR-T Therapy Market Size by Application (2017-2022) 9.3.2 Latin America TCR-T Therapy Market Size by Application (2023-2028) 9.3.3 Latin America TCR-T Therapy Market Share by Application (2017-2028) 9.4 Latin America TCR-T Therapy Market Size by Country 9.4.1 Latin America TCR-T Therapy Market Size by Country (2017-2022) 9.4.2 Latin America TCR-T Therapy Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil10 Middle East & Africa 10.1 Middle East & Africa TCR-T Therapy Market Size (2017-2028) 10.2 Middle East & Africa TCR-T Therapy Market Size by Type 10.2.1 Middle East & Africa TCR-T Therapy Market Size by Type (2017-2022) 10.2.2 Middle East & Africa TCR-T Therapy Market Size by Type (2023-2028) 10.2.3 Middle East & Africa TCR-T Therapy Market Share by Type (2017-2028) 10.3 Middle East & Africa TCR-T Therapy Market Size by Application 10.3.1 Middle East & Africa TCR-T Therapy Market Size by Application (2017-2022) 10.3.2 Middle East & Africa TCR-T Therapy Market Size by Application (2023-2028) 10.3.3 Middle East & Africa TCR-T Therapy Market Share by Application (2017-2028) 10.4 Middle East & Africa TCR-T Therapy Market Size by Country 10.4.1 Middle East & Africa TCR-T Therapy Market Size by Country (2017-2022) 10.4.2 Middle East & Africa TCR-T Therapy Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE11 Key Players Profiles 11.1 Athenex 11.1.1 Athenex Company Details 11.1.2 Athenex Business Overview 11.1.3 Athenex TCR-T Therapy Introduction 11.1.4 Athenex Revenue in TCR-T Therapy Business (2017-2022) 11.1.5 Athenex Recent Developments 11.2 Xiangxue Pharmaceutical (Xiangxue Precision) 11.2.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Details 11.2.2 Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview 11.2.3 Xiangxue Pharmaceutical (Xiangxue Precision) TCR-T Therapy Introduction 11.2.4 Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in TCR-T Therapy Business (2017-2022) 11.2.5 Xiangxue Pharmaceutical (Xiangxue Precision) Recent Developments 11.3 Hengrui Yuanzheng 11.3.1 Hengrui Yuanzheng Company Details 11.3.2 Hengrui Yuanzheng Business Overview 11.3.3 Hengrui Yuanzheng TCR-T Therapy Introduction 11.3.4 Hengrui Yuanzheng Revenue in TCR-T Therapy Business (2017-2022) 11.3.5 Hengrui Yuanzheng Recent Developments 11.4 Eureka Therapeutics 11.4.1 Eureka Therapeutics Company Details 11.4.2 Eureka Therapeutics Business Overview 11.4.3 Eureka Therapeutics TCR-T Therapy Introduction 11.4.4 Eureka Therapeutics Revenue in TCR-T Therapy Business (2017-2022) 11.4.5 Eureka Therapeutics Recent Developments 11.5 WuXi Juno 11.5.1 WuXi Juno Company Details 11.5.2 WuXi Juno Business Overview 11.5.3 WuXi Juno TCR-T Therapy Introduction 11.5.4 WuXi Juno Revenue in TCR-T Therapy Business (2017-2022) 11.5.5 WuXi Juno Recent Developments 11.6 Shenzhen Inno Immunity 11.6.1 Shenzhen Inno Immunity Company Details 11.6.2 Shenzhen Inno Immunity Business Overview 11.6.3 Shenzhen Inno Immunity TCR-T Therapy Introduction 11.6.4 Shenzhen Inno Immunity Revenue in TCR-T Therapy Business (2017-2022) 11.6.5 Shenzhen Inno Immunity Recent Developments 11.7 Shenzhen Binde Bio 11.7.1 Shenzhen Binde Bio Company Details 11.7.2 Shenzhen Binde Bio Business Overview 11.7.3 Shenzhen Binde Bio TCR-T Therapy Introduction 11.7.4 Shenzhen Binde Bio Revenue in TCR-T Therapy Business (2017-2022) 11.7.5 Shenzhen Binde Bio Recent Developments 11.8 Kerui Bio 11.8.1 Kerui Bio Company Details 11.8.2 Kerui Bio Business Overview 11.8.3 Kerui Bio TCR-T Therapy Introduction 11.8.4 Kerui Bio Revenue in TCR-T Therapy Business (2017-2022) 11.8.5 Kerui Bio Recent Developments12 Analyst's Viewpoints/Conclusions13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer